Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

Since SARS-CoV-2, the novel coronavirus that causes coronavirus disease 2019 , was first detected in December 2019 (1), approximately 1.3 million cases have been reported worldwide (2), including approximately 330,000 in the United States (3). To conduct population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in the United States, the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) was created using the existing infrastructure of the Influenza Hospitalization Surveillance Network (FluSurv-NET) (4) and the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET). This report presents age-stratified COVID-19-associated hospitalization…

• UD
  U.S. Department of Health and Human Services
• UD
  U.S. Department of Veterans Affairs
• P
  Pfizer
• S
  Sanofi
• P
  PepsiCo
• NY
  New York State Department of Health
• MD
  Minnesota Department of Health
• YU
  Yale University
• CO
  Council of State and Territorial Epidemiologists
• VU
  Vanderbilt University
• EU
  Emory University
• CD
  Colorado Department of Public Health and Environment
• UO
  University of Rochester
• ID
  Iowa Department of Public Health
• RP
  Regeneron Pharmaceuticals
• MD
  Michigan Department of Health and Human Services
• OD
  Ohio Department of Health
• N
  Novavax
• OR
  Oak Ridge Institute for Science and Education
• SO
  School of Medicine, Vanderbilt University
• SO
  School of Medicine, Emory University